• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

霍奇金病治疗后至乳腺癌发生的时间间隔。

Time interval to the development of breast carcinoma after treatment for Hodgkin disease.

作者信息

Wendland Merideth M M, Tsodikov Alexander, Glenn Martha J, Gaffney David K

机构信息

Department of Radiation Oncology, The Huntsman Cancer Institute, Salt Lake City, Utah, USA.

出版信息

Cancer. 2004 Sep 15;101(6):1275-82. doi: 10.1002/cncr.20516.

DOI:10.1002/cncr.20516
PMID:15316904
Abstract

BACKGROUND

Women with Hodgkin disease (HD) who received mantle irradiation had an increased risk of developing breast carcinoma. The authors examined the influence of radiotherapy on the time interval to the development of breast carcinoma.

METHODS

Using population, cancer incidence, and survival data from the Surveillance, Epidemiology, and End Results (SEER) registries, standardized incidence ratios (SIR) were calculated and Kaplan-Meier curves were constructed to estimate breast carcinoma-free survival in women with HD treated with and without radiotherapy. The log-rank test was utilized and multivariate proportional hazard regression analysis was performed. Multivariate analysis was also performed using the PHPH regression model.

RESULTS

In 9 SEER registries, 8036 females were identified who were diagnosed with HD between 1973 and 1999. Of these women, 183 (2.3%) were subsequently diagnosed with breast carcinoma. The use of radiotherapy in the treatment of HD resulted in an increased risk of development of breast carcinoma (SIR = 1.90, P < 0.01). The log-rank test and proportional hazard regression model failed to detect a difference (P = 0.79) in breast carcinoma-free survival for women treated with and without radiotherapy. The PHPH regression model revealed that the use of radiotherapy had an adverse effect on long-term survival (relative risk [RR] = 1.84, P = 0.01), but was associated with a short-term survival advantage (RR = 0.45, P = 0.01).

CONCLUSIONS

Use of the PHPH model indicated that the use of radiotherapy in the treatment of HD resulted in an increased long-term risk for the subsequent development of breast carcinoma, but conferred a short-term reduction.

摘要

背景

接受斗篷野照射的霍奇金淋巴瘤(HD)女性患乳腺癌的风险增加。作者研究了放疗对乳腺癌发病时间间隔的影响。

方法

利用监测、流行病学和最终结果(SEER)登记处的人群、癌症发病率和生存数据,计算标准化发病率比(SIR),并构建Kaplan-Meier曲线以估计接受和未接受放疗的HD女性的无乳腺癌生存率。采用对数秩检验并进行多变量比例风险回归分析。还使用PHPH回归模型进行多变量分析。

结果

在9个SEER登记处中,确定了8036名在1973年至1999年间被诊断为HD的女性。在这些女性中,183名(2.3%)随后被诊断为乳腺癌。HD治疗中使用放疗导致患乳腺癌的风险增加(SIR = 1.90,P < 0.01)。对数秩检验和比例风险回归模型未能检测出接受和未接受放疗的女性在无乳腺癌生存率方面的差异(P = 0.79)。PHPH回归模型显示,放疗的使用对长期生存有不利影响(相对风险[RR] = 1.84,P = 0.01),但与短期生存优势相关(RR = 0.45,P = 0.01)。

结论

使用PHPH模型表明,HD治疗中使用放疗会增加随后患乳腺癌的长期风险,但可带来短期风险降低。

相似文献

1
Time interval to the development of breast carcinoma after treatment for Hodgkin disease.霍奇金病治疗后至乳腺癌发生的时间间隔。
Cancer. 2004 Sep 15;101(6):1275-82. doi: 10.1002/cncr.20516.
2
Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.霍奇金淋巴瘤女性幸存者的乳腺癌风险:较小放疗体积后的风险较低。
J Clin Oncol. 2009 Sep 10;27(26):4239-46. doi: 10.1200/JCO.2008.19.9174. Epub 2009 Aug 10.
3
Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma.接受保乳手术或乳房切除术治疗原发性乳腺癌的女性在放疗后发生的肺癌。
Cancer. 2003 Mar 15;97(6):1404-11. doi: 10.1002/cncr.11214.
4
[Breast cancer after mantle field irradiation for Hodgkin's disease].[霍奇金病斗篷野照射后发生的乳腺癌]
Harefuah. 2000 May 15;138(10):823-5, 911.
5
Does radiotherapy around the time of pregnancy for Hodgkin's disease modify the risk of breast cancer?妊娠期间针对霍奇金淋巴瘤进行放疗会改变患乳腺癌的风险吗?
Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1474-9. doi: 10.1016/j.ijrobp.2003.09.018.
6
Breast cancer in women following mantle irradiation for Hodgkin's disease.霍奇金病斗篷野照射后女性患乳腺癌的情况。
Am Surg. 1995 Sep;61(9):763-6.
7
Second neoplasms after megavoltage radiation for pediatric tumors.小儿肿瘤大剂量放疗后的第二原发肿瘤。
Cancer. 2003 May 15;97(10):2588-96. doi: 10.1002/cncr.11356.
8
The risk of multiple primary breast and thyroid carcinomas.原发性乳腺癌和甲状腺癌并存的风险。
Cancer. 2003 Sep 15;98(6):1309-17. doi: 10.1002/cncr.11626.
9
Pelvic radiotherapy and the risk of secondary leukemia and multiple myeloma.盆腔放疗与继发性白血病和多发性骨髓瘤风险。
Cancer. 2010 May 15;116(10):2486-92. doi: 10.1002/cncr.25067.
10
Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.视网膜母细胞瘤幸存者发生二次恶性肿瘤的风险:超过40年的随访
J Natl Cancer Inst. 2008 Dec 17;100(24):1771-9. doi: 10.1093/jnci/djn394. Epub 2008 Dec 9.

引用本文的文献

1
Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era.现代治疗的早期经典型霍奇金淋巴瘤患者发生第二原发恶性肿瘤的风险
Cancer Med. 2015 Apr;4(4):513-8. doi: 10.1002/cam4.405. Epub 2015 Jan 26.
2
Risk, characteristics, and prognosis of breast cancer after Hodgkin's lymphoma.霍奇金淋巴瘤后乳腺癌的风险、特征和预后。
Oncologist. 2012;17(6):783-91. doi: 10.1634/theoncologist.2011-0451. Epub 2012 May 15.
3
Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study.
霍奇金淋巴瘤患者发生乳腺癌后的长期生存:一项基于人群的研究。
J Clin Oncol. 2010 Dec 1;28(34):5088-96. doi: 10.1200/JCO.2010.29.5683. Epub 2010 Oct 25.